Semaglutide Weight Loss Results: Real Data

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as one of the most effective medications for weight management available today. Multiple clinical studies demonstrate that people using semaglutide achieve measurable weight loss within 12–16 weeks, with cumulative results continuing to improve over 12 months or longer. PlexusDx offers compounded semaglutide injections starting at $149/month, allowing patients to access this therapy without insurance requirements or membership fees.

Average Weight Loss on Compounded Semaglutide

The STEP trials, large randomized controlled studies, revealed that participants receiving semaglutide 2.4 mg weekly lost an average of 15% of their baseline body weight over 68 weeks—significantly more than placebo groups. In real-world settings, weight loss typically ranges from 10% to 20% of starting body weight, depending on individual factors like metabolism, adherence, and lifestyle modifications. Some patients experience even greater results, particularly those who combine medication with structured nutrition and activity changes.

Weight loss typically begins within the first 2–4 weeks as semaglutide reduces appetite and increases feelings of fullness. By week 8–12, most patients notice meaningful changes on the scale and in how clothing fits. The medication continues working throughout the entire treatment period, with results generally plateauing between months 4 and 6 before stabilizing at a new, lower weight.

Factors That Influence Individual Semaglutide Results

Not everyone loses the same amount of weight on semaglutide, even at identical doses. Starting body weight, age, insulin resistance level, physical activity, dietary composition, sleep quality, and stress hormones all shape the final outcome. Patients with a higher baseline weight often experience larger absolute weight loss, while those with metabolic conditions may respond more slowly initially but can achieve substantial results over time.

Genetic variations in peptide-pathway genes directly affect how your body responds to semaglutide. The PlexusDx Precision Peptide Genetic Test identifies key variants in GLP1R, GIPR, FTO, and MC4R—pathways that control hunger signals, satiety, and fat metabolism. Understanding your genetic predispositions allows PlexusDx clinicians to personalize your starting dose and titration schedule, optimizing the likelihood of meaningful weight loss while minimizing side effects.

Dose Escalation and Progressive Weight Loss Outcomes

Compounded semaglutide treatment typically begins at a low dose (0.25 mg weekly) and increases gradually over 4–8 weeks, allowing your body to adapt and reducing nausea or other GI side effects. As doses increase, weight loss acceleration often follows, with many patients experiencing their most significant progress between weeks 8 and 20. The medication reaches steady-state levels in your bloodstream after about 4 weeks at each dose level.

PlexusDx emphasizes that your dose may need to go up, but your price won't—compounded semaglutide injection starts at $149/month regardless of dose tier, making higher therapeutic doses accessible without additional cost. This pricing structure removes barriers to reaching optimal doses that maximize your individual weight loss potential while staying within budget.

Maintaining Weight Loss After Reaching Your Goal

Research shows that weight regain occurs in approximately 50% of patients who stop semaglutide within one year, highlighting the importance of ongoing treatment. PlexusDx supports long-term therapy with consistent monthly pricing, allowing patients to maintain results indefinitely without escalating costs. Combining medication with sustained lifestyle habits—regular movement, protein-rich nutrition, and stress management—creates the most durable weight loss outcomes.

Some patients successfully transition to lower maintenance doses once they reach their goal weight, which PlexusDx can facilitate through clinical review and adjustment. Others maintain full therapeutic doses to prevent weight regain. Both approaches are supported by evidence, and your PlexusDx clinician will help you determine the strategy that aligns with your health goals and circumstances.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does it take to see weight loss results on semaglutide?

Most patients notice initial weight loss within 2–4 weeks of starting treatment, with more significant changes visible by week 8–12. Results continue accumulating over 12–24 weeks as doses increase and your body adapts to the medication's appetite-suppressing effects.

Is 10–15% weight loss realistic for most people?

Clinical trial data supports 10–15% average weight loss over 68 weeks, though individual results vary. Some patients achieve 20% or more, while others may reach 8–12%, depending on genetics, lifestyle, and consistency with treatment.

Can I get compounded semaglutide without insurance?

Yes. PlexusDx serves all 50 states with no insurance requirement, membership fee, or membership commitment. Compounded semaglutide injection starts at $149/month and is HSA/FSA eligible, making it accessible regardless of insurance status.

What happens if I stop taking semaglutide?

Weight regain typically begins within weeks to months after stopping semaglutide, with approximately 50% of weight returning within one year. Long-term treatment with PlexusDx maintains results and prevents rebound weight gain through consistent, affordable monthly therapy.

How does genetic testing help predict my weight loss on semaglutide?

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that directly influence appetite regulation and fat metabolism. These insights help your clinician personalize your starting dose and titration schedule for optimal results based on your unique biology.

How Much Weight Do People Lose on Compounded Semaglutide?